Embracing Future Holdings Limited (SGX:8YY)

Market Cap	140.41M
Revenue (ttm)	2.49M
Net Income (ttm)	-2.61M
Shares Out	1.73B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,047,000
Average Volume	25,344,885
Open	0.0770
Previous Close	0.0770
Day's Range	0.0740 - 0.0820
52-Week Range	0.0160 - 0.0820
Beta	0.52
RSI	83.97
Earnings Date	Oct 31, 2025

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 7
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 8YY

Financial Performance

In 2024, Embracing Future Holdings's revenue was 858,000, an increase of 176.77% compared to the previous year's 310,000. Losses were -3.43 million, 38.0% more than in 2023.